相关实验视频
Updated: Jun 19, 2026
06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
EGF受体为SOS依赖性皮肤瘤的发展提供了必要的生存信号
M Sibilia1, A Fleischmann, A Behrens
1Research Institute of Molecular Pathology, Vienna, Austria. maria.sibilia@univie.ac.at
Cell
|August 16, 2000
概括
皮表皮肤生长因子受体 (EGFR) 对于皮肤发育至关重要,并在瘤转化过程中防止细胞死亡. 抑制EGFR可能为各种上皮瘤提供治疗策略.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 表皮生长因子受体 (EGFR) 在皮肤发育中起着关键作用,并与表皮瘤形成有关.
- 在转基因小鼠的基底角质细胞中,主导阴性七无之子 (SOS-F) 表达导致皮肤乳头瘤.
- EGFR在瘤转化和瘤发育中的作用需要进一步阐明.
研究的目的:
- 研究EGFR作为瘤转化中的生存因子的作用.
- 为了确定EGFR是否对SOS-F启动的瘤形成至关重要.
- 探索EGFR作为在上皮瘤中潜在的治疗点.
主要方法:
- 在基底角质细胞中表达SOS-F的转基因小鼠的生成.
- 使用EGFR低形态 (wa2) 和零突变小鼠.
- 使用SOS-F和rasV12.12进行EGFR缺乏纤维细胞的转化试验.
- 用抗亡bcl-2基因恢复瘤发生性实验.
- 在乳头瘤和初级角质细胞中分析细胞灭亡和Akt酸化.
- 移植实验以评估细胞自主EGFR的要求.
主要成果:
- 在K5-SOS-F转基因小鼠中的瘤形成在EGFR缺乏背景中被抑制.
- 缺乏EGFR的纤维细胞对SOS-F和rasV12.12的转化具有抗性.
- 在EGFR缺乏的细胞中,bcl-2的表达恢复了瘤性.
- K5-SOS-F乳头瘤和wa2角质细胞表现出亡的增加和Akt酸化的减少.
- 移植实验证实了基质细胞对EGFR的细胞自主需求.
结论:
- 在瘤转化过程中,EGFR起到关键的生存因素的作用.
- EGFR对状细胞的存活和瘤发育至关重要,由瘤信号发射启动.
- EGFR对比之前预期的更广泛的瘤来说是一个有价值的治疗点.
相关概念视频
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
01:12Renewal of Skin Epidermal Stem Cells
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...